ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$3.49
+2.35% today
Updated 2026-04-30
Market cap
$3.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.56
Dividend yield
—
52W range
$3 – $86
Volume
4.2M
Artelo Biosciences Inc (ARTL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15269.00 | $-13502.00 | $-18489.00 | $-216821.00 | $-1.61M | $-2.79M | $-4.35M | $-6.14M | $-8.01M | $-8.21M | $-8.35M | $-8.52M |
| Capital expenditures | $0.00 | $845.00 | $845.00 | $845.00 | $845.00 | $1.50M | $1.50M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | $3332.00 | $290004.00 | $425110.00 | $377766.00 | $1.53M | $2.46M | $1.02M | $818000.00 | $1.14M |
| Free cash flow | $-15269.00 | $-14347.00 | $-19334.00 | $-217666.00 | $-1.61M | $-4.29M | $-5.85M | $-6.14M | $-8.01M | $-8.21M | $-8.35M | $-8.52M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |